Growth Hormone Deficiency Market Size to Hit USD 8.5 Billion by 2032 | SNS Insider Pune, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Growth Hormone Deficiency Market Size & Share Analysis: “According to SNS Insider, The Growth hormone deficiency Market was valued at USD 5.4 billion...

Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults – Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin® / Macrilen™ in Europe as the Company plans to pursue even greater protection TORONTO, ONTARIO,...

Aeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency – Company actively monitoring delays to mitigate potential impact of COVID-19 and conflict in Ukraine following Russian invasion on the estimated completion dates for the trial – Patient...